News from veracyte, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 02, 2014, 07:30 ET

Veracyte Inc. to Host Investor Day on October 9, 2014

 Veracyte Inc. (Nasdaq: VCYT) today announced that the company will host a live webcast in conjunction with its Investor Day on Thursday,...

Sep 17, 2014, 07:30 ET

Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer

Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced the promotion of...

Sep 04, 2014, 16:30 ET

Veracyte, Inc. to Acquire Allegro Diagnostics, Accelerating Entry Into Pulmonology Market

 Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced an agreement to...

Sep 02, 2014, 07:30 ET

Veracyte to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2014

 Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present in a fireside chat...

Aug 13, 2014, 16:05 ET

Veracyte, Inc. Announces Second Quarter 2014 Financial Results

Veracyte, Inc. (Nasdaq: VCYT) today reported financial results for the second quarter ended June 30, 2014, and provided an update on business...

Aug 06, 2014, 07:30 ET

Veracyte, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2014 Financial Results on August 13, 2014

 Veracyte, Inc. (Nasdaq: VCYT) announced today that its second quarter 2014 financial results will be released after close of market on...

Jul 03, 2014, 07:30 ET

Veracyte Announces Positive Coverage Policies for Afirma® Gene Expression Classifier from Highmark Inc. and Horizon Blue Cross Blue Shield of New Jersey

 Veracyte, Inc., a molecular diagnostics company pioneering the field of molecular cytology, today announced that two Blue Cross Blue Shield...

Jun 23, 2014, 07:30 ET

Veracyte Comments On Preliminary American Thyroid Association Guidelines Regarding Thyroid Nodule Management

 Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today commented on preliminary...

Jun 18, 2014, 07:30 ET

Veracyte to Present at JMP Securities 2014 Healthcare Conference

 Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the JMP...

Jun 16, 2014, 07:30 ET

Veracyte Named a 2014 "Top Workplace" in the San Francisco Bay Area

 Veracyte, Inc. (Nasdaq: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that it has been...

Jun 03, 2014, 07:30 ET

Veracyte to Present at 2014 William Blair Growth Stock Conference

 Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the 2014 William...

May 28, 2014, 07:30 ET

Veracyte to Present at Jefferies 2014 Global Healthcare Conference

 Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the Jefferies...

May 20, 2014, 11:15 ET

Veracyte Presents Preliminary Data for Molecular Classifier to Improve Early, Non-Surgical Diagnosis of Idiopathic Pulmonary Fibrosis

Veracyte, Inc. (Nasdaq: VCYT) announced the presentation of the first proof-of-concept data demonstrating the company's ability to develop a...

May 13, 2014, 07:30 ET

Veracyte, Inc. Launches Afirma® Malignancy Classifiers to Further Help Thyroid Nodule Patients Avoid Unnecessary Surgeries and Lower Healthcare Costs

 Veracyte, Inc. (Nasdaq: VCYT) today announced the launch of its Afirma Malignancy Classifiers to further establish the Afirma Thyroid FNA...

May 08, 2014, 16:05 ET

Veracyte, Inc. Announces First Quarter 2014 Financial Results

Veracyte, Inc. (Nasdaq: VCYT) today reported financial results for the first quarter ended March 31, 2014, and provided an update on recent...

May 07, 2014, 07:30 ET

Preliminary Data Supporting Veracyte Molecular Classifier for Idiopathic Pulmonary Fibrosis (IPF) Diagnosis to be Presented at ATS 2014

Veracyte, Inc. (Nasdaq: VCYT) announced that early data demonstrating the company's ability to develop a molecular classifier differentiating...

May 06, 2014, 07:30 ET

New Data Validating Veracyte's Afirma® Malignancy Classifiers to be Presented at AACE Congress

 Veracyte, Inc. (Nasdaq: VCYT) today announced that four abstracts supporting the use of the company's Afirma Malignancy Classifiers and...

May 02, 2014, 07:30 ET

Veracyte and Fleury Announce Partnership to Make the Afirma® Gene Expression Classifier Available to Patients in Brazil

 Veracyte, Inc. (Nasdaq: VCYT) and Fleury Medicine and Health today announced a new partnership that will make Veracyte's Afirma Gene...

May 01, 2014, 07:30 ET

Veracyte, Inc. to Host Conference Call and Webcast to Discuss First Quarter 2014 Financial Results on May 8, 2014

 Veracyte, Inc. (Nasdaq: VCYT) announced today that its first quarter 2014 financial results will be released after close of market on...

Mar 18, 2014, 16:05 ET

Veracyte, Inc. Announces Fourth Quarter and Full-Year 2013 Financial Results, Provides 2014 Financial Outlook

Veracyte, Inc. (Nasdaq: VCYT) today reported financial results and business progress for the quarter and full year ended December 31, 2013, and...